HN2002000331A - PHARMACEUTICAL COMPOSITIONS OF 5,7,14-TRIAZATETRA-CYCLE (10.3.1.02,11.04,9) -HEXADECA-2 (11) 3,5,7,9-PENTAENO - Google Patents

PHARMACEUTICAL COMPOSITIONS OF 5,7,14-TRIAZATETRA-CYCLE (10.3.1.02,11.04,9) -HEXADECA-2 (11) 3,5,7,9-PENTAENO

Info

Publication number
HN2002000331A
HN2002000331A HN2002000331A HN2002000331A HN2002000331A HN 2002000331 A HN2002000331 A HN 2002000331A HN 2002000331 A HN2002000331 A HN 2002000331A HN 2002000331 A HN2002000331 A HN 2002000331A HN 2002000331 A HN2002000331 A HN 2002000331A
Authority
HN
Honduras
Prior art keywords
pentaeno
triazatetra
hexadeca
cycle
pharmaceutical compositions
Prior art date
Application number
HN2002000331A
Other languages
Spanish (es)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Priority to HN2002000331A priority Critical patent/HN2002000331A/en
Publication of HN2002000331A publication Critical patent/HN2002000331A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A COMPOSICIONES FARMACEUTICAS DE 5,7,14-TRIAZATETRA-CICLO (10.3.1.02,11.04,9)-HEXADECA-2(11) 3,5,7,9-PENTAENOTHIS INVENTION REFERS TO PHARMACEUTICAL COMPOSITIONS OF 5,7,14-TRIAZATETRA-CYCLE (10.3.1.02,11.04,9) -HEXADECA-2 (11) 3,5,7,9-PENTAENO

HN2002000331A 2002-11-27 2002-11-27 PHARMACEUTICAL COMPOSITIONS OF 5,7,14-TRIAZATETRA-CYCLE (10.3.1.02,11.04,9) -HEXADECA-2 (11) 3,5,7,9-PENTAENO HN2002000331A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HN2002000331A HN2002000331A (en) 2002-11-27 2002-11-27 PHARMACEUTICAL COMPOSITIONS OF 5,7,14-TRIAZATETRA-CYCLE (10.3.1.02,11.04,9) -HEXADECA-2 (11) 3,5,7,9-PENTAENO

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HN2002000331A HN2002000331A (en) 2002-11-27 2002-11-27 PHARMACEUTICAL COMPOSITIONS OF 5,7,14-TRIAZATETRA-CYCLE (10.3.1.02,11.04,9) -HEXADECA-2 (11) 3,5,7,9-PENTAENO

Publications (1)

Publication Number Publication Date
HN2002000331A true HN2002000331A (en) 2003-02-10

Family

ID=53183916

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2002000331A HN2002000331A (en) 2002-11-27 2002-11-27 PHARMACEUTICAL COMPOSITIONS OF 5,7,14-TRIAZATETRA-CYCLE (10.3.1.02,11.04,9) -HEXADECA-2 (11) 3,5,7,9-PENTAENO

Country Status (1)

Country Link
HN (1) HN2002000331A (en)

Similar Documents

Publication Publication Date Title
HN1999000066A (en) PHARMACEUTICAL FORMULATIONS
BR0207640A (en) Oral pharmaceutical composition of cefpodoxima proxetil
UY28290A1 (en) NEW PHARMACEUTICAL COMPOUNDS
DE60225040D1 (en) MONTELUKAST GRANULES Formulation
HN2001000244A (en) SPIROPIRIMIDIN INHIBITORS - 2, 4, 6 - TRIONA METALOPROTEINASAS.
HN2001000139A (en) STABILIZED INTERLEUQUINA 2
CO5590918A2 (en) FORMULATIONS
PL375874A1 (en) 2,6-Diisopropylphenol aqueous pharmaceutical compositions
BRPI0417950A (en) pharmaceutical compositions
UY27250A1 (en) PHENYL-HETEROCICLIL-CTERES
HN1998000045A (en) PHARMACEUTICAL COMPOSITIONS
TNSN06012A1 (en) Emulsifying systems containing azetidine derivatives
NO20063293L (en) Pharmaceutical compounds
MXPA06000636A (en) Semi-solid formulations for the oral administration of taxoids.
HN1998000102A (en) SOLTRILIZED COMPOSITIONS OF SERTRALINA
HN2002000331A (en) PHARMACEUTICAL COMPOSITIONS OF 5,7,14-TRIAZATETRA-CYCLE (10.3.1.02,11.04,9) -HEXADECA-2 (11) 3,5,7,9-PENTAENO
BRPI0408209A (en) new compositions
ECSP066292A (en) SEMI-SOLID SYSTEMS CONTAINING DERIVATIVES OF AZETIDINE
HN2000000089A (en) POLYMORPHES OF A CRYSTALLINE DICLOHYDRATE OF AZOBICICLO (2,2,2) OCT - 3 - ILAMINE AND ITS PHARMACEUTICAL COMPOSITIONS.
HN2000000276A (en) THIAZOLILAMIDE DERIVATIVES
HN2000000062A (en) SUBSTITUTED BENZOLACTAMA COMPOUNDS
HN2002000368A (en) RECONSTITUABLE PARENTAL COMPOSITION
HN2001200000A (en) ZIPRASIDONA SUSPENSION
HN2000000279A (en) PHARMACEUTICAL COMPOSITIONS THAT PROVIDE POTENTIAL CONCENTRATIONS OF FARMACO.
HN2002000084A (en) FENIL - HETEROCICLIL - ETERES